Articles published by Gamida Cell
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
September 28, 2022
From Gamida Cell
Via Business Wire
Tickers
GMDA
Gamida Cell Announces FDA Clearance of IND and Removal of Clinical Hold for NK Cell Therapy Candidate GDA-201
April 26, 2022
From Gamida Cell
Via Business Wire
Tickers
GMDA